Filing Details

Accession Number:
0001209191-23-035862
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-09 16:26:47
Reporting Period:
2023-06-07
Accepted Time:
2023-06-09 16:26:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501756 Adverum Biotechnologies Inc. ADVM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321937 M Linda Rubinstein C/O Adverum Biotechnologies, Inc.
100 Cardinal Way
Redwood City CA 94063
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-07 100,000 $1.45 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.